导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.21% | 646/924 |
| 近一周 | 0.04% | 198/971 |
| 近一月 | -0.11% | 908/958 |
| 近一季 | 0.31% | 681/954 |
| 近半年 | 0.31% | 848/936 |
| 近一年 | 1.48% | 506/921 |
| 近两年 | 6.24% | 80/820 |
| 近三年 | 11.08% | 28/692 |
| 成立以来 | 23.87% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
0.24% 307/917 |
0.79% 205/957 |
-0.23% 905/973 |
- - |
| 2024 | 4.51% 58/908 |
1.28% 87/846 |
1.40% 20/862 |
-0.01% 801/878 |
1.77% 43/908 |
| 2023 | 4.18% 111/832 |
1.41% 79/751 |
1.37% 44/771 |
0.58% 344/802 |
0.77% 479/832 |
| 2022 | 1.39% 442/729 |
0.36% 440/525 |
1.13% 55/610 |
1.22% 33/652 |
-1.31% 641/729 |
| 2021 | 4.68% 39/489 |
1.05% 35/330 |
1.14% 56/361 |
1.42% 35/413 |
0.99% 84/489 |
| 2020 | 2.03% 190/351 |
1.77% 31/251 |
-0.42% 246/292 |
-0.03% 248/302 |
0.70% 153/329 |
| 2019 | 3.74% 48/249 |
0.59% 1418/1682 |
1.02% 201/1825 |
1.29% 21/207 |
0.79% 122/237 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 华夏中短债债券A VS. () |